AI Article Synopsis
- Risperidone is an atypical antipsychotic first approved for treating schizophrenia, but it has several common side effects like weight gain, anxiety, and increased prolactin levels.
- More rare side effects include leukopenia, a condition involving low white blood cell count.
- The case presented involves a 66-year-old man who developed leukopenia after starting risperidone for agitation related to delirium, and the article will discuss previous cases and risk factors for this side effect.
Article Abstract
Risperidone is an atypical antipsychotic agent that was originally approved by the United States Food and Drug Adminstration for the treatment of schizophrenia. There are many side effects that are frequently associated with the use of risperidone. These include weight gain, anxiety, extra-pyramidal side effects, and elevated prolactin levels. More infrequently, the use of risperidone has been linked to leukopenia. We will now present the case of a 66-year-old gentleman who developed leukopenia after the initiation of risperidone to control agitation due to delirium. We will review the previous cases of leukopenia associated with risperidone, and will review possible risk factors for the development of leukopenia, based on the reported cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1574886312666170531072837 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!